Stock INFI.Q INFINITY PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Infinity Pharmaceuticals, Inc.

Equities

INFI.Q

US45665G3039

End-of-day quote OTC Markets
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Infinity Pharmaceuticals, Inc. 0.00% -99.96%
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ
Mar. 25 Infinity Pharmaceuticals, Inc. Went Out of Business CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
AQ
North American Morning Briefing : Tech in Focus on -2-
DJ
Infinity Pharmaceuticals, Inc. Went Out of Business
CI
Revised Liquidation Plan Approved for Infinity Pharmaceuticals, Inc.
CI
Motion for Di Minimis Assets Sale Approved for Infinity Pharmaceuticals, Inc.
CI
An unknown healthcare investment firm acquired Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q).
CI
First Motion for Exclusivity Period Extension Approved For Infinity Pharmaceuticals, Inc.
CI
Disclosure Statement Approved on Interim Basis for Infinity Pharmaceuticals, Inc.
CI
First Motion for Exclusivity Period Extension Filed by Infinity Pharmaceuticals, Inc.
CI
North American Morning Briefing : Tech Likely to -2-
DJ
North American Morning Briefing : Stock Futures Waver Ahead of Bank-Earnings Bonanza
DJ
Joint Liquidation Plan and Disclsoure Statement Filed by Infinity Pharmaceuticals, Inc.
CI
Motion for Asset Sale Approved for Infinity Pharmaceuticals, Inc.
CI
North American Morning Briefing : Bond Yields Rise -2-
DJ
North American Morning Briefing : Stock Futures Gain as 2023 Draws to a Close
DJ
North American Morning Briefing : Stock Futures -2-
DJ
North American Morning Briefing : Investors Await -2-
DJ
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 | Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.
AQ
North American Morning Briefing : Stock Futures, -2-
DJ
North American Morning Briefing : Stock Futures -2-
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INFI.Q Stock
  4. News Infinity Pharmaceuticals, Inc.